share_log

Cantor Fitzgerald Reiterates Overweight on BioVie, Maintains $11 Price Target

Benzinga ·  Aug 22, 2023 09:21

Cantor Fitzgerald analyst Charles Duncan reiterates BioVie (NASDAQ:BIVI) with a Overweight and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment